| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.28 | 0.3 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |